Neurocrine Biosciences (NBIX) announced the appointment of Lewis Choi as Chief Information Officer, effective June 9. Choi, an accomplished leader with 25 years of experience in information technology and artificial intelligence, will be responsible for driving the vision and long-term strategic direction of the company’s technology initiatives. Choi joins Neurocrine after a 13-year career at Thermo Fisher Scientific (TMO), most recently as the Vice President of AI Automation & Data.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NBIX:
- Neurocrine announces new data from Phase 4 KINECT-PRO study
- Neurocrine Announces Leadership Transition with New CMO
- Neurocrine’s NBI-568 Clinical Advancements Justify Buy Rating Amid Competitive Efficacy and Strong Safety Profile
- Neurocrine’s NBI-1117568 shows new positive Phase 2 results in schizophrenia
- Neurocrine Holds Annual Meeting, Approves Key Matters